JP2008515778A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008515778A5 JP2008515778A5 JP2007528024A JP2007528024A JP2008515778A5 JP 2008515778 A5 JP2008515778 A5 JP 2008515778A5 JP 2007528024 A JP2007528024 A JP 2007528024A JP 2007528024 A JP2007528024 A JP 2007528024A JP 2008515778 A5 JP2008515778 A5 JP 2008515778A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- group
- drug
- effective amount
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60267504P | 2004-08-18 | 2004-08-18 | |
| PCT/US2005/029455 WO2006033734A2 (en) | 2004-08-18 | 2005-08-17 | Combination compositions comprising 13-cis-retinyl derivatives and uses thereof to treat opthalmic disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008515778A JP2008515778A (ja) | 2008-05-15 |
| JP2008515778A5 true JP2008515778A5 (https=) | 2008-09-11 |
Family
ID=35351948
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007528024A Pending JP2008515778A (ja) | 2004-08-18 | 2005-08-17 | 眼の状態を１３−シス−レチニル誘導体で処置するための組み合わせ方法、組成物および治療 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20080254140A1 (https=) |
| EP (1) | EP1778207A2 (https=) |
| JP (1) | JP2008515778A (https=) |
| AU (1) | AU2005287343A1 (https=) |
| CA (1) | CA2575265A1 (https=) |
| WO (1) | WO2006033734A2 (https=) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3326623A1 (en) | 2003-03-14 | 2018-05-30 | University of Washington | Retinoid replacements and opsin agonists and methods for the use thereof |
| NZ587006A (en) | 2004-06-18 | 2011-12-22 | Univ Washington | 11-cis-Retinal derivatives and methods for the use thereof for the treatment of visual disorders |
| PL1768657T3 (pl) | 2004-06-23 | 2009-01-30 | Revision Therapeutics Inc | Sposoby i kompozycje do leczenia stanów ocznych za pomocą pochodnych retinylowych |
| US20060089411A1 (en) * | 2004-08-07 | 2006-04-27 | Gierhart Dennis L | Treatment of Stargardt's disease and other lipofuscin disorders with combined retinaldehyde inhibitor and zeaxanthin |
| JP2008519054A (ja) | 2004-11-04 | 2008-06-05 | シリオン セラピューティクス， インコーポレイテッド | レチノール−レチノール結合タンパク質（ｒｂｐ）−トランスチレチン（ｔｔｒ）複合体の形成のモジュレーター |
| CA2584845C (en) * | 2004-12-08 | 2009-02-17 | Sirion Therapeutics, Inc. | Methods, assays and compositions for treating retinol-related diseases |
| UA81382C2 (en) * | 2005-07-11 | 2007-12-25 | Composition for treating retinol-related diseases by modulation of retinol binding | |
| WO2008013984A2 (en) * | 2006-07-27 | 2008-01-31 | University Of Florida Research Foundation, Inc. | Compositions and methods for treating or preventing ophthalmic disease |
| US8613946B2 (en) | 2006-12-21 | 2013-12-24 | Isp Investment Inc. | Carotenoids of enhanced bioavailability |
| WO2009035673A1 (en) * | 2007-09-12 | 2009-03-19 | Trustees Of Columbia University In The City Of Newyork | Compositions and methods for treating macular degeneration |
| WO2009102418A1 (en) | 2008-02-11 | 2009-08-20 | University Of Washington | Methods for the treatment and prevention of age-related retinal dysfunction |
| IN2012DN00352A (https=) | 2009-06-16 | 2015-08-21 | Bikam Pharmaceuticals Inc | |
| CN102612375B (zh) | 2009-09-15 | 2016-01-27 | Qlt股份有限公司 | 含有在脂质媒介物中的9-顺式-视黄酯的药物制剂 |
| WO2011059474A1 (en) * | 2009-10-30 | 2011-05-19 | Nestec S.A. | Methods for maintaining eye health and ameliorating opthalmic maladies in canines |
| CN107308143A (zh) | 2010-04-19 | 2017-11-03 | 诺维利昂治疗股份有限公司 | 用于治疗或改善与内源性类视黄醇缺乏有关的视觉障碍的治疗方案和方法 |
| GB201014340D0 (en) * | 2010-08-27 | 2010-10-13 | Piraee Mahmood | Nutritional supplement formulation comprising saffron and resveratrol |
| JP5951625B2 (ja) | 2010-11-24 | 2016-07-13 | ザ・トラスティーズ・オブ・コランビア・ユニバーシティー・イン・ザ・シティー・オブ・ニューヨークＴｈｅ Ｔｒｕｓｔｅｅｓ Ｏｆ Ｃｏｌｕｍｂｉａ Ｕｎｉｖｅｒｓｉｔｙ Ｉｎ Ｔｈｅ Ｃｉｔｙ Ｏｆ Ｎｅｗ Ｙｏｒｋ | 加齢性黄斑変性症およびシュタルガルト病の処置のための非レチノイドｒｂｐ４アンタゴニスト |
| WO2012135432A2 (en) * | 2011-03-29 | 2012-10-04 | Kemin Industries, Inc. | Dyes for membranes and biological structures |
| JP6576636B2 (ja) | 2012-03-01 | 2019-09-18 | ノベリオン セラピューティクス インコーポレイテッド | 内因性レチノイド欠乏に関連する視覚障害における視覚機能を改善するための治療的計画および方法 |
| WO2013166040A1 (en) * | 2012-05-01 | 2013-11-07 | The Trustees Of Columbia University In The City Of New York | S-fta and s-fta analogues capable of inhibiting retinol-dependent rbp4-ttr interaction for treatment of age-related macular degeneration, stargardt disease, and other retinal disease characterized by excessive lipofuscin accumulation |
| US9333202B2 (en) | 2012-05-01 | 2016-05-10 | The Trustees Of Columbia University In The City Of New York | Non-retinoid antagonists for treatment of age-related macular degeneration and stargardt disease |
| KR101423631B1 (ko) * | 2012-08-17 | 2014-07-25 | 주식회사파마킹 | 에스-알릴엘-시스테인을 유효성분으로 포함하는 안질환 예방 또는 치료용 조성물 및 이를 포함하는 의약제제 |
| EP3495357B1 (en) | 2013-03-14 | 2021-05-05 | The Trustees of Columbia University in the City of New York | 4-phenylpiperidines, their preparation and use |
| WO2014152018A1 (en) | 2013-03-14 | 2014-09-25 | The Trustees Of Columbia University In The City Of New York | Octahydrocyclopentapyrroles, their preparation and use |
| US9938291B2 (en) | 2013-03-14 | 2018-04-10 | The Trustess Of Columbia University In The City Of New York | N-alkyl-2-phenoxyethanamines, their preparation and use |
| US9944644B2 (en) | 2013-03-14 | 2018-04-17 | The Trustees Of Columbia University In The City Of New York | Octahydropyrrolopyrroles their preparation and use |
| ES3012058T3 (en) * | 2014-02-13 | 2025-04-08 | Katairo Gmbh | Compounds for the treatment of lipofuscin related diseases |
| SG11201608943VA (en) | 2014-04-30 | 2016-11-29 | Univ Columbia | Substituted 4-phenylpiperidines, their preparaiton and use |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6506917B1 (en) * | 1991-12-18 | 2003-01-14 | The Salk Institute For Biological Studies | Compounds and compositions useful for modulation of processes mediated by RXR |
| US5824685A (en) * | 1995-02-01 | 1998-10-20 | The Johns Hopkins University School Of Medicine | Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists |
| CO5150167A1 (es) * | 1998-12-04 | 2002-04-29 | Johnson & Johnson Consumer | Composiciones para el cuidado de la piel, que contienen sales de cinc y retinoides |
| JP2002533169A (ja) * | 1998-12-29 | 2002-10-08 | オキュロジックス コーポレイション | レオロジー的処置方法および関連するアフェレーシスシステム |
| US20030032078A1 (en) * | 2001-01-23 | 2003-02-13 | Board Of Regents, The University Of Texas System | Methods and compositions for the treatment of macular and retinal degenerations |
| CN1717234A (zh) * | 2002-12-06 | 2006-01-04 | 爱尔康公司 | 用于治疗眼紊乱和疾病的超氧化物岐化酶模拟物 |
| MXPA05005937A (es) * | 2002-12-06 | 2005-08-18 | Alcon Inc | Imitaciones de superoxido de dismutasa para el tratamiento de trastornos y enfermedades oculares. |
| JP2007525496A (ja) * | 2004-02-17 | 2007-09-06 | プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ | 黄班変性症を含む眼科疾患の管理 |
| US20080176952A1 (en) * | 2004-02-17 | 2008-07-24 | Rando Robert R | Management of Ophthalmologic Disorders, Including Macular Degeneration |
| US7566808B2 (en) * | 2004-02-17 | 2009-07-28 | President And Fellows Of Harvard College | Management of ophthalmologic disorders, including macular degeneration |
| PL1768657T3 (pl) * | 2004-06-23 | 2009-01-30 | Revision Therapeutics Inc | Sposoby i kompozycje do leczenia stanów ocznych za pomocą pochodnych retinylowych |
| JP2008519054A (ja) * | 2004-11-04 | 2008-06-05 | シリオン セラピューティクス， インコーポレイテッド | レチノール−レチノール結合タンパク質（ｒｂｐ）−トランスチレチン（ｔｔｒ）複合体の形成のモジュレーター |
-
2005
- 2005-08-17 AU AU2005287343A patent/AU2005287343A1/en not_active Abandoned
- 2005-08-17 JP JP2007528024A patent/JP2008515778A/ja active Pending
- 2005-08-17 WO PCT/US2005/029455 patent/WO2006033734A2/en not_active Ceased
- 2005-08-17 CA CA002575265A patent/CA2575265A1/en not_active Abandoned
- 2005-08-17 EP EP05788621A patent/EP1778207A2/en not_active Withdrawn
- 2005-08-18 US US11/659,915 patent/US20080254140A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008515778A5 (https=) | ||
| CN107929743B (zh) | 治疗肺部疾病的高穿透力前药组合物和医药组合物 | |
| AU2005235422B2 (en) | New pharmaceutical compositions for the treatment of sexual disorders II | |
| NO339538B1 (no) | Blanding for behandling av inflammatoriske sykdommer | |
| CA2569691A1 (en) | Methods and compositions for treating ophthalmic conditions with retinyl derivatives | |
| KR20200006630A (ko) | 로플루밀라스트 n- 옥사이드의 흡입에 의한 자가면역, 호흡 및 염증성 장애의 치료방법 | |
| EP1497289B1 (de) | Arzneimittel enthaltend betamimetika und ein neues anticholinergikum | |
| DE10007203A1 (de) | Neue Kombination nichtsedierender Antihistaminika mit Substanzen, die die Leukotrienwirkung beeinflussen, zur Behandlung der Rhinitis/Konjunktivitis | |
| JP5784012B2 (ja) | 眼、耳または鼻の感染症を処置するためのフィナフロキサシンを含む組成物および方法 | |
| SI2600830T1 (en) | Dry powder formulation comprising a phosphodiesterase inhibitor | |
| JP2002525319A (ja) | 眼、耳および鼻治療用の抗生物質組成物 | |
| JP2010539168A5 (https=) | ||
| JP6261011B2 (ja) | 眼疾患処置薬 | |
| JP2009500455A5 (https=) | ||
| NZ628124A (en) | Pharmaceutical compositions to reduce complications of ocular steroid | |
| CN106170206A (zh) | 视神经病变治疗和用稳定的多不饱和物质减少类固醇诱导的氧化应激 | |
| BRPI0517204A (pt) | sulfato de levosalbutamol cristalino (forma i), sulfato de levosalbutamol cristalino (forma ii), sulfato de levosalbutamol cristalino (forma iii), processo para preparar a forma i do sulfato de levosalbutamol cristalino, processo para preparar a forma ii do sulfato de levosalbutamol cristalino, processo para preparar a forma iii do sulfato de levosalbutamol, composição farmacêutica, composto, combinação, pó seco para inalador, processo para preparar um pó seco para inalador, processo para preparar uma composição famacêutica, processo para fabricação de uma composição farmacêutica, método para tratamento de um mamìfero, e uso de uma combinação de salbutamol | |
| JP2007534755A5 (https=) | ||
| CA2416535A1 (en) | Non-sedating barbiturate compounds as neuroprotective agents | |
| JP2007326877A5 (https=) | ||
| JP2015522544A5 (https=) | ||
| CA2662732A1 (en) | Use of a pharmaceutical composition comprising an anticholinergic for killing microorganisms and for treating respiratory tract infections | |
| ME00242B (me) | Formulacija rastvora za inhalaciju sa soli tiotropijuma | |
| JP2011246464A (ja) | ジクロフェナクナトリウムを封入した後眼部到達用ポリマーコーティングリポソーム | |
| JP6474913B2 (ja) | 外用剤 |